Shopping Cart
- Remove All
Your shopping cart is currently empty
HIV-1inhibitor-66 is an orally active non-nucleoside reverse transcriptase inhibitor (NNRTI) that exhibits inhibitory activity against wild-type HIV-1 reverse transcriptase (HIV-1 reverse transcriptase) with an IC50 of 40 nM.

| Description | HIV-1inhibitor-66 is an orally active non-nucleoside reverse transcriptase inhibitor (NNRTI) that exhibits inhibitory activity against wild-type HIV-1 reverse transcriptase (HIV-1 reverse transcriptase) with an IC50 of 40 nM. |
| In vitro | HIV-1 inhibitor-66 (compound 10n) effectively inhibits wild-type (WT) HIV-1 (IIIB) and NNRTI-resistant strains. The EC 50 values for HIV-1 IIIB, L100I, K103N, Y181C, Y188L, E138K, F227L/V106A, and RES056 (K103N/Y181C) are 0.009 μM, 0.011 μM, 0.013 μM, 0.018 μM, 0.703 μM, 0.013 μM, 17.7 μM, and 0.059 μM, respectively. |
| In vivo | HIV-1 inhibitor-66 (compound 10n) exhibits excellent pharmacokinetic properties in rats, characterized by a half-life (T 1/2) of 5.09 hours and a bioavailability (F) of 108.96%. It has been verified to have no acute or subacute toxicity in vivo, with an LD50 greater than 2000 mg/kg. |
| Formula | C22H15BrClF3N4O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.